<DOC>
	<DOCNO>NCT02686125</DOCNO>
	<brief_summary>To compile characteristic real-world outcome Boston Scientific Corporation 's commercially approve VerciseTM Deep Brain Stimulation ( DBS ) Systems treatment dystonia .</brief_summary>
	<brief_title>Registry Deep Brain Stimulation With VERCISEâ„¢ System Treatment Dystonia : Vercise DBS Dystonia Registry</brief_title>
	<detailed_description>To compile characteristic real-world outcome Boston Scientific Corporation 's commercially approve VerciseTM Deep Brain Stimulation ( DBS ) Systems treatment dystonia . Subjects ' improvement disease symptom overall Quality life assess .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<criteria>Inclusion Criteria ( IC ) : IC1 . Meets criteria establish locally applicable Vercise System Directions Use ( DFU ) dystonia . IC2 . At least 7 year old . Parent guardian consent require patient young 18 year time consent . Exclusion Criteria ( EC ) : EC1 . Meets contraindication Vercise System locally applicable Directions Use .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>